In line with the ESC mission, newly presented content is made available to all for a limited time (4 months for ESC Congress, 3 months for other events). ESC Professional Members, Association Members (Ivory & above) benefit from year-round access to all the resources from their respective Association, and to all content from previous years. Fellows of the ESC (FESC), and Professionals in training or under 40 years old, who subscribed to a Young Combined Membership package benefit from access to all ESC 365 content from all events, all editions, all year long. Find out more about ESC Memberships here.
Higher prevalence of cardiac abnormalities including diastolic dysfunction in gout patients with low cardiovascular risk profile using cardiac MRI and echocardiography
EOF Van Gorselen1
J Van Es3
C Von Birgelen6
1Slingeland Hospital, Cardiology - Doetinchem - Netherlands
2Scheper Hospital, Cardiology - Emmen - Netherlands
3Medical Spectrum Twente, Cardiology - Enschede - Netherlands
4Radboud University Medical Centre, Rheumatology - Nijmegen - Netherlands
5Medical Spectrum Twente, Rheumatology - Enschede - Netherlands
6University of Twente - Enschede - Netherlands
Purpose: Gout is associated with increased cardiovascular (CV) morbidity and mortality. To investigate gout-specific CV pathology a pilot study was performed to study cardiac abnormalities on echocardiography and MRI in low CV risk profile gout patients. Methods: 10 male patients with chrystal proven gout were recruited from the Arthritis Center Twente CardioVascular Disease database. For inclusion only one of the following CV risk factors smoking, hypercholesterolemia or hypertension was allowed. Exclusion criteria were previous CV disease, age <18 or >75 years, kidney dysfunction, diabetes mellitus and BMI > 30. Results: Median age was 61.5 years, median BMI was 26 kg/m2, no current smoking. 50% of patients had no CV risk factors. Three patients had elevated blood pressure; median SBP was 138 mmHg, DBP 79 mmHg. Two patients used statins. Median LDL was 2.9 mmol/L. Eight out of 10 patients used urate lowering medication and median serum urate was 0,59 mmol/L. One patient did not undergo echocardiography. 70% had diastolic dysfunction. One patient had asymptomatic atrial fibrillation, 4 left ventricular hypertrophy with concentric remodelling, 3 valvular calcification without significant stenosis and 1 had dilatation of the ascending aorta. Cardiac MRI showed no myocardial edema, but in one patient late gadolinium enhancement and in two regional wall motion abnormalities. Conclusions: Low CV risk profile gout patients had substantial cardiac abnormalities on echocardiography and cardiac MRI, in particular diastolic dysfunction. The presence of gout-specific CV risk is suggested. Non-invasive cardiac imaging may be useful to detect early subclinical CV pathology.
LV function echocardiography
LV function MRI
2D EF (%)
LV mass/BSA (g/m2)
LV mass/BSA (g/m2)
Diastolic dysfunction grade (n=)
LV: left ventricle, EF: ejection fraction, LAVI: left atrial volume index, RV: right ventricle
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.
Our mission: To reduce the burden of cardiovascular disease